Announcement
25 Nov 2024
In November 2024, the Administration for Strategic Preparedness and Response (ASPR) announced two Defense Production Act (DPA) Title III funding initiatives to address drug shortages by supporting Active Pharmaceutical Ingredient (API) production.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
25 Nov 2024
Revocation date:
No revocation date
Updated: 25 Nov 2024
State aid, unspecified
In force
On 25 November 2024, the Administration for Strategic Preparedness and Response (ASPR) awarded USD 12 million to Antheia Inc to support the production of key starting materials and active pharmaceutic...
Sign in to see more
Updated: 25 Nov 2024
State aid, unspecified
In force
On 25 November 2024, the Administration for Strategic Preparedness and Response (ASPR) awarded USD 32.4 million to Manus Bio Inc to expand its facilities for the production of key starting materials f...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.